Details of the Drug
General Information of Drug (ID: DMA8E10)
| Drug Name |
Sodium salicylate
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Salicylate, sodium; Sodium salicylic acid; o-Hydroxybenzoic sodium salt; WLN: QVR BQ &-NA-; Sodium salicylate (NaO3C7H5); HMS3652M03; Pharmakon1600-01500533; NSC757313; NSC202167; NSC-757313; NSC-202167; SC-18508; SR-01000722015
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| ATC Code | |||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL is unavailable | 2D MOL | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||

